Imagion Biosystems Valuation
| IBXXF Stock | USD 0.04 0.00 0.00% |
Imagion Biosystems seems to be overvalued based on Macroaxis valuation methodology. Our model calculates the value of Imagion Biosystems from evaluating the firm fundamentals such as Return On Asset of -0.44, shares outstanding of 1.12 B, and Return On Equity of -0.94 as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Imagion Biosystems' price fluctuation is very steady at this time. Calculation of the real value of Imagion Biosystems is based on 3 months time horizon. Increasing Imagion Biosystems' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Imagion pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Imagion Biosystems Limited. Since Imagion Biosystems is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Imagion Pink Sheet. However, Imagion Biosystems' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.035 | Real 0.0294 | Hype 0.035 | Naive 0.035 |
The real value of Imagion Pink Sheet, also known as its intrinsic value, is the underlying worth of Imagion Biosystems Company, which is reflected in its stock price. It is based on Imagion Biosystems' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Imagion Biosystems' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Imagion Biosystems Limited helps investors to forecast how Imagion pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Imagion Biosystems more accurately as focusing exclusively on Imagion Biosystems' fundamentals will not take into account other important factors: Imagion Biosystems Total Value Analysis
Imagion Biosystems Limited is currently anticipated to have takeover price of 21.85 M with market capitalization of 28.03 M, debt of 5.12 M, and cash on hands of 8.52 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Imagion Biosystems fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
21.85 M | 28.03 M | 5.12 M | 8.52 M |
Imagion Biosystems Investor Information
The book value of the company was currently reported as 0.01. The company recorded a loss per share of 0.0. Imagion Biosystems had not issued any dividends in recent years. Based on the key indicators related to Imagion Biosystems' liquidity, profitability, solvency, and operating efficiencyBased on the analysis of, Imagion Biosystems Limited is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.Imagion Biosystems Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Imagion Biosystems has an asset utilization ratio of 1.65 percent. This implies that the Company is making $0.0165 for each dollar of assets. An increasing asset utilization means that Imagion Biosystems Limited is more efficient with each dollar of assets it utilizes for everyday operations.Imagion Biosystems Ownership Allocation
Imagion Biosystems Limited has a total of 1.12 Billion outstanding shares. Imagion Biosystems retains 9.27 (percent) of its outstanding shares held by insiders and 0.0 (percent) owned by outside corporations. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Imagion Biosystems Profitability Analysis
The company reported the revenue of 232.87 K. Net Loss for the year was (6.02 M) with profit before overhead, payroll, taxes, and interest of 151.53 K.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Imagion Biosystems' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Imagion Biosystems and how it compares across the competition.
About Imagion Biosystems Valuation
The pink sheet valuation mechanism determines Imagion Biosystems' current worth on a weekly basis. Our valuation model uses a comparative analysis of Imagion Biosystems. We calculate exposure to Imagion Biosystems's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Imagion Biosystems's related companies.Imagion Biosystems Limited provides medical imaging technologies based on superparamagnetic relaxometry for cancer and disease detection, and monitoring therapy. The company was incorporated in 2016 and is based in San Diego, California. Imagion Biosystems operates under Diagnostics Research classification in the United States and is traded on OTC Exchange.
8 Steps to conduct Imagion Biosystems' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Imagion Biosystems' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Imagion Biosystems' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Imagion Biosystems' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Imagion Biosystems' revenue streams: Identify Imagion Biosystems' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Imagion Biosystems' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Imagion Biosystems' growth potential: Evaluate Imagion Biosystems' management, business model, and growth potential.
- Determine Imagion Biosystems' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Imagion Biosystems' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Imagion Biosystems Growth Indicators
Investing in growth stocks can be very risky. If the company such as Imagion Biosystems does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 1.1 B | |
| Retained Earnings | -46 M |
Complementary Tools for Imagion Pink Sheet analysis
When running Imagion Biosystems' price analysis, check to measure Imagion Biosystems' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Imagion Biosystems is operating at the current time. Most of Imagion Biosystems' value examination focuses on studying past and present price action to predict the probability of Imagion Biosystems' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Imagion Biosystems' price. Additionally, you may evaluate how the addition of Imagion Biosystems to your portfolios can decrease your overall portfolio volatility.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |